These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 2574083

  • 1. Effect of subacute cabergoline treatment on prolactin, thyroid stimulating hormone and growth hormone response to simultaneous administration of thyrotrophin-releasing hormone and growth hormone-releasing hormone in hyperprolactinaemic women.
    Giusti M, Lomeo A, Torre R, Sghedoni D, Mazzocchi G, Durante R, Giordano G.
    Clin Endocrinol (Oxf); 1989 Mar; 30(3):315-21. PubMed ID: 2574083
    [Abstract] [Full Text] [Related]

  • 2. Pituitary responsiveness to GH-releasing hormone, GH-releasing peptide-2 and thyrotrophin-releasing hormone in critical illness.
    Van den Berghe G, de Zegher F, Bowers CY, Wouters P, Muller P, Soetens F, Vlasselaers D, Schetz M, Verwaest C, Lauwers P, Bouillon R.
    Clin Endocrinol (Oxf); 1996 Sep; 45(3):341-51. PubMed ID: 8949573
    [Abstract] [Full Text] [Related]

  • 3. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion.
    Alba-Roth J, Müller OA, Schopohl J, von Werder K.
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1186-9. PubMed ID: 2903866
    [Abstract] [Full Text] [Related]

  • 4. Hypothalamic derangement in traumatized patients: growth hormone (GH) and prolactin response to thyrotrophin-releasing hormone and GH-releasing hormone.
    De Marinis L, Mancini A, Valle D, Bianchi A, Gentilella R, Liberale I, Mignani V, Pennisi M, Della Corte F.
    Clin Endocrinol (Oxf); 1999 Jun; 50(6):741-7. PubMed ID: 10468946
    [Abstract] [Full Text] [Related]

  • 5. Interaction of L-dopa and GHRH on GH secretion in normal men.
    Alba-Roth J, von Creytz C, Mehltretter G, Schopohl J, Müller OA, von Werder K.
    J Endocrinol Invest; 1989 Dec; 12(11):783-7. PubMed ID: 2515218
    [Abstract] [Full Text] [Related]

  • 6. The higher the growth hormone response to growth hormone releasing hormone the lower the response to bromocriptine and thyrotrophin releasing hormone in acromegaly.
    Smals AE, Pieters GF, Smals AG, Hermus AR, Benraad TJ, Kloppenborg PW.
    Clin Endocrinol (Oxf); 1987 Jul; 27(1):43-7. PubMed ID: 3115634
    [Abstract] [Full Text] [Related]

  • 7. Effect of simultaneous administration of GHRH (1-40) and TRH on GH, PRL and TSH secretion in normal man.
    Giusti M, Lomeo A, Mazzocchi G, Torre R, Monachesi M, Sessarego P, Attanasio R, Giordano G.
    J Endocrinol Invest; 1986 Dec; 9(6):497-501. PubMed ID: 3106459
    [Abstract] [Full Text] [Related]

  • 8. Growth hormone, prolactin and thyrotrophin responses to thyrotrophin-releasing hormone in diabetic patients.
    Harrower AD.
    Postgrad Med J; 1980 Jul; 56(657):481-4. PubMed ID: 6777767
    [Abstract] [Full Text] [Related]

  • 9. Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness.
    Van den Berghe G, Wouters P, Bowers CY, de Zegher F, Bouillon R, Veldhuis JD.
    Eur J Endocrinol; 1999 Jan; 140(1):17-22. PubMed ID: 10037246
    [Abstract] [Full Text] [Related]

  • 10. Hexarelin, a synthetic growth hormone releasing peptide, stimulates prolactin secretion in acromegalic but not in hyperprolactinaemic patients.
    Ciccarelli E, Grottoli S, Razzore P, Gianotti L, Arvat E, Deghenghi R, Camanni G, Ghigo E.
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):67-71. PubMed ID: 8706295
    [Abstract] [Full Text] [Related]

  • 11. The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas.
    Di Sarno A, Landi ML, Marzullo P, Di Somma C, Pivonello R, Cerbone G, Lombardi G, Colao A.
    Clin Endocrinol (Oxf); 2000 Jul; 53(1):53-60. PubMed ID: 10931080
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness and tolerability of long term treatment with cabergoline, a new long-lasting ergoline derivative, in hyperprolactinemic patients.
    Ciccarelli E, Giusti M, Miola C, Potenzoni F, Sghedoni D, Camanni F, Giordano G.
    J Clin Endocrinol Metab; 1989 Oct; 69(4):725-8. PubMed ID: 2570790
    [Abstract] [Full Text] [Related]

  • 13. Inhibitory influence of thyrotropin releasing hormone administration on growth hormone response to low doses of growth hormone-releasing hormone in normal man.
    Zanoboni A, Gibillini M, Cucchi MR, Zanoboni Muciaccia W, Zanussi C.
    J Endocrinol Invest; 1988 Jun; 11(6):413-7. PubMed ID: 3145297
    [Abstract] [Full Text] [Related]

  • 14. Divergence between growth hormone responses to insulin-induced hypoglycaemia and growth hormone-releasing hormone in patients with non-functioning pituitary macroadenomas and hyperprolactinaemia.
    Beentjes JA, Tjeerdsma G, Sluiter WJ, Dullaart RP.
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):391-8. PubMed ID: 8959076
    [Abstract] [Full Text] [Related]

  • 15. Prolactin response to growth hormone-releasing hormone during chronic thyrotropin-releasing hormone infusion in the treatment of amyotrophic lateral sclerosis.
    Chiodini PG, Attanasio R, Liuzzi A, Cozzi R, Orlandi P, De Palo C, Dallabonzana D, Girotti F, Testa D.
    J Endocrinol Invest; 1990 Sep; 13(8):631-6. PubMed ID: 2125610
    [Abstract] [Full Text] [Related]

  • 16. Long-lasting lowering of serum growth hormone and prolactin levels by single and repetitive cabergoline administration in dopamine-responsive acromegalic patients.
    Ferrari C, Paracchi A, Romano C, Gerevini G, Boghen M, Barreca A, Fortini P, Dubini A.
    Clin Endocrinol (Oxf); 1988 Nov; 29(5):467-76. PubMed ID: 2908102
    [Abstract] [Full Text] [Related]

  • 17. Influence of suckling and of suckling followed by TRH or LH-RH on plasma prolactin, TSH, GH and FSH.
    Jeppsson S, Nilsson KO, Rannevik G, Wide L.
    Acta Endocrinol (Copenh); 1976 Jun; 82(2):246-53. PubMed ID: 818858
    [Abstract] [Full Text] [Related]

  • 18. Effects of hypothalamic dopamine on growth hormone-releasing hormone-induced growth hormone secretion and thyrotropin-releasing hormone-induced prolactin secretion in goats.
    Jin J, Hashizume T.
    Anim Sci J; 2015 Jun; 86(6):634-40. PubMed ID: 25442325
    [Abstract] [Full Text] [Related]

  • 19. Cholinergic modulation of growth hormone, prolactin and thyroid stimulating hormone responses to thyrotropin-releasing hormone in normal aging.
    Giusti M, Giovale M, Sessarego P, Carraro A, Pompei A, Giordano G.
    Recenti Prog Med; 1995 Sep; 86(9):341-4. PubMed ID: 7569294
    [Abstract] [Full Text] [Related]

  • 20. Ethanol decreases nocturnal plasma levels of thyrotropin and growth hormone but not those of thyroid hormones or prolactin in man.
    Ekman AC, Vakkuri O, Ekman M, Leppäluoto J, Ruokonen A, Knip M.
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2627-32. PubMed ID: 8675588
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.